{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:39:03Z","timestamp":1789821543703,"version":"4.0.1"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11,27]]},"DOI":"10.1097\/tp.0b013e3181bcccea","type":"journal-article","created":{"date-parts":[[2009,11,22]],"date-time":"2009-11-22T03:15:55Z","timestamp":1258859755000},"page":"1149-1156","source":"Crossref","is-referenced-by-count":32,"title":["Fibrogenesis in Kidney Transplantation: Potential Targets for Prevention and Therapy"],"prefix":"10.1097","volume":"88","author":[{"given":"Arjang","family":"Djamali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millie","family":"Samaniego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210211","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/j.1600-6143.2005.01050.x","article-title":"Predicting subsequent decline in kidney allograft function from early surveillance biopsies.","volume":"5","author":"Cosio","year":"2005","journal-title":"Am J Transplant"},{"key":"R2-1-20210211","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.semnephrol.2007.02.009","article-title":"TG. F-beta in renal injury and disease.","volume":"27","author":"Bottinger","year":"2007","journal-title":"Semin Nephrol"},{"key":"R3-1-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trre.2007.09.004","article-title":"Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis.","volume":"22","author":"Bedi","year":"2008","journal-title":"Transplant Rev (Orlando)"},{"key":"R4-1-20210211","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1681\/ASN.2007101160","article-title":"Early epithelial phenotypic changes predict graft fibrosis.","volume":"19","author":"Hertig","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R5-1-20210211","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI39675","article-title":"EMT: When epithelial cells decide to become mesenchymal-like cells.","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"R6-1-20210211","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrneph.2009.74","article-title":"Fibroblast activation and myofibroblast generation in obstructive nephropathy.","volume":"5","author":"Grande","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"R7-1-20210211","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2006.01654.x","article-title":"Beneficial effects of CCR1 blockade on the progression of chronic renal allograft damage.","volume":"7","author":"Bedke","year":"2007","journal-title":"Am J Transplant"},{"key":"R8-1-20210211","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1097\/01.ASN.0000130082.67775.60","article-title":"Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice.","volume":"15","author":"Anders","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R9-1-20210211","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1111\/j.1523-1755.2004.66038.x","article-title":"CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.","volume":"66","author":"Vielhauer","year":"2004","journal-title":"Kidney Int"},{"key":"R10-1-20210211","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1172\/JCI0214040","article-title":"A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation.","volume":"109","author":"Anders","year":"2002","journal-title":"J Clin Invest"},{"key":"R11-1-20210211","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1046\/j.1523-1755.2002.00148.x","article-title":"Early application of Met-RANTES ameliorates chronic allograft nephropathy.","volume":"61","author":"Song","year":"2002","journal-title":"Kidney Int"},{"key":"R12-1-20210211","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2741\/2734","article-title":"The role of chemokines and chemokine receptors in diabetic nephropathy.","volume":"13","author":"Ruster","year":"2008","journal-title":"Front Biosci"},{"key":"R13-1-20210211","doi-asserted-by":"crossref","first-page":"F445","DOI":"10.1152\/ajprenal.00037.2007","article-title":"OS as a common pathway to chronic tubulointerstitial injury in kidney allografts.","volume":"293","author":"Djamali","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"R14-1-20210211","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1681\/ASN.2004050425","article-title":"Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.","volume":"16","author":"Rhyu","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R15-1-20210211","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-6143.2008.02463.x","article-title":"Nox-2 is a modulator of fibrogenesis in kidney allografts.","volume":"9","author":"Djamali","year":"2009","journal-title":"Am J Transplant"},{"key":"R16-1-20210211","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1089-8603(02)00132-5","article-title":"Long-term dietary L-arginine supplementation attenuates proteinuria and focal glomerulosclerosis in experimental chronic renal transplant failure.","volume":"8","author":"Albrecht","year":"2003","journal-title":"Nitric Oxide"},{"key":"R17-1-20210211","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/00005344-200309000-00017","article-title":"Oxidative stress in chronic renal allograft nephropathy in rats: Effects of long-term treatment with carvedilol, BM 910228, or alpha-tocopherol.","volume":"42","author":"Gottmann","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"R18-1-20210211","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00007890-199401001-00010","article-title":"The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants.","volume":"57","author":"Land","year":"1994","journal-title":"Transplantation"},{"key":"R19-1-20210211","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00007890-199301000-00011","article-title":"A randomized double-blind trial of the use of human recombinant superoxide dismutase in renal transplantation.","volume":"55","author":"Pollak","year":"1993","journal-title":"Transplantation"},{"key":"R20-1-20210211","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/j.1600-6143.2005.00931.x","article-title":"Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: A systematic review of randomized trials.","volume":"5","author":"Mulay","year":"2005","journal-title":"Am J Transplant"},{"key":"R21-1-20210211","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation.","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"R22-1-20210211","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0140-6736(05)77739-4","article-title":"Prope tolerance, perioperative campath 1H, and low-dose cyclosporine monotherapy in renal allograft recipients.","volume":"351","author":"Calne","year":"1998","journal-title":"Lancet"},{"key":"R23-1-20210211","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1034\/j.1600-6143.2003.00120.x","article-title":"Campath-1H induction plus rapamycin monotherapy for renal transplantation: Results of a pilot study.","volume":"3","author":"Knechtle","year":"2003","journal-title":"Am J Transplant"},{"key":"R24-1-20210211","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-6143.2007.02053.x","article-title":"Alemtuzumab (Campath-1H) in kidney transplantation.","volume":"8","author":"Ciancio","year":"2008","journal-title":"Am J Transplant"},{"key":"R25-1-20210211","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJMoa050085","article-title":"Costimulation blockade with belatacept in renal transplantation.","volume":"353","author":"Vincenti","year":"2005","journal-title":"N Engl J Med"},{"key":"R27-1-20210211","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/hc0302.102618","article-title":"The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis, part I: Oxidative stress and atherogenesis.","volume":"105","author":"Nickenig","year":"2002","journal-title":"Circulation"},{"key":"R28-1-20210211","doi-asserted-by":"crossref","first-page":"F955","DOI":"10.1152\/ajprenal.00246.2002","article-title":"Angiotensin II induces apoptosis in renal proximal tubular cells.","volume":"284","author":"Bhaskaran","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"R29-1-20210211","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1152\/ajpregu.00476.2002","article-title":"Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression.","volume":"285","author":"Chabrashvili","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R30-1-20210211","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.hjh.0000191244.91314.9d","article-title":"Blockade of the renin-angiotensin-aldosterone system: A key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes.","volume":"24","author":"Burnier","year":"2006","journal-title":"J Hypertens"},{"key":"R31-1-20210211","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1681\/ASN.V9101948","article-title":"Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism.","volume":"9","author":"Amuchastegui","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"R32-1-20210211","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1681\/ASN.2005090955","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.","volume":"17","author":"Heinze","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R33-1-20210211","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1681\/ASN.2006050543","article-title":"No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: A Collaborative Transplant Study Report.","volume":"17","author":"Opelz","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R34-1-20210211","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/j.1600-6143.2007.01928.x","article-title":"Renin angiotensin system blockade in kidney transplantation: A systematic review of the evidence.","volume":"7","author":"Hiremath","year":"2007","journal-title":"Am J Transplant"},{"key":"R35-1-20210211","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1038\/sj.onc.1208927","article-title":"TGF-beta and epithelial-to-mesenchymal transitions.","volume":"24","author":"Zavadil","year":"2005","journal-title":"Oncogene"},{"key":"R36-1-20210211","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/j.1600-6143.2006.01339.x","article-title":"Chronic allograft nephropathy: Intraepithelial signals generated by transforming growth factor-beta and bone morphogenetic protein-7.","volume":"6","author":"Tyler","year":"2006","journal-title":"Am J Transplant"},{"key":"R37-1-20210211","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1046\/j.1523-1755.1999.00423.x","article-title":"Chronic rejection of mouse kidney allografts.","volume":"55","author":"Mannon","year":"1999","journal-title":"Kidney Int"},{"key":"R38-1-20210211","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/00007890-199903270-00016","article-title":"Transforming growth factor (TGF)-beta mimics and anti-TGF-beta antibody abrogates the in vivo effects of cyclosporine: Demonstration of a direct role of TGF-beta in immunosuppression and nephrotoxicity of cyclosporine.","volume":"67","author":"Khanna","year":"1999","journal-title":"Transplantation"},{"key":"R39-1-20210211","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/359693a0","article-title":"Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.","volume":"359","author":"Shull","year":"1992","journal-title":"Nature"},{"key":"R40-1-20210211","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00007890-200202270-00016","article-title":"High transforming growth factor-beta and extracellular matrix mRNA response in renal allografts during early acute rejection is associated with absence of chronic rejection.","volume":"73","author":"Eikmans","year":"2002","journal-title":"Transplantation"},{"key":"R41-1-20210211","first-page":"S239","article-title":"Pirfenidone prevents collagen accumulation in the remnant kidney in rats with partial nephrectomy.","volume":"63","author":"Shimizu","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"R42-1-20210211","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1523-1755.1998.00962.x","article-title":"Pirfenidone improves renal function and fibrosis in the post-obstructed kidney.","volume":"54","author":"Shimizu","year":"1998","journal-title":"Kidney Int"},{"key":"R43-1-20210211","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1034\/j.1600-6143.2002.020201.x","article-title":"Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity.","volume":"2","author":"Shihab","year":"2002","journal-title":"Am J Transplant"},{"key":"R44-1-20210211","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1600-6143.2005.00876.x","article-title":"Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway.","volume":"5","author":"Liu","year":"2005","journal-title":"Am J Transplant"},{"key":"R45-1-20210211","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2215\/CJN.01050207","article-title":"Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis.","volume":"2","author":"Cho","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R46-1-20210211","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1358\/dnp.2005.18.10.959578","article-title":"Rho\/Rho kinase as a potential target for the treatment of renal disease.","volume":"18","author":"Wakino","year":"2005","journal-title":"Drug News Perspect"},{"key":"R47-1-20210211","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1172\/JCI200319270","article-title":"Targeted disruption of TGF-beta1\/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.","volume":"112","author":"Sato","year":"2003","journal-title":"J Clin Invest"},{"key":"R48-1-20210211","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1046\/j.1523-1755.2002.00328.x","article-title":"Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction.","volume":"61","author":"Nagatoya","year":"2002","journal-title":"Kidney Int"},{"key":"R49-1-20210211","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/FJC.0b013e318064f150","article-title":"Fasudil attenuates myocardial fibrosis in association with inhibition of monocyte\/macrophage infiltration in the heart of DOCA\/salt hypertensive rats.","volume":"50","author":"Ishimaru","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"R50-1-20210211","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1677\/JOE-06-0045","article-title":"A rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy in insulin-resistant diabetic rats.","volume":"192","author":"Kikuchi","year":"2007","journal-title":"J Endocrinol"},{"key":"R51-1-20210211","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0014-2999(02)02619-5","article-title":"Fasudil attenuates interstitial fibrosis in rat kidneys with unilateral ureteral obstruction.","volume":"455","author":"Satoh","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"R52-1-20210211","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1359-6101(97)00010-5","article-title":"Connective tissue growth factor: A mediator of TGF-beta action on fibroblasts.","volume":"8","author":"Grotendorst","year":"1997","journal-title":"Cytokine Growth Factor Rev"},{"key":"R53-1-20210211","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.2007111261","article-title":"CTGF inhibits BMP-7 signaling in diabetic nephropathy.","volume":"19","author":"Nguyen","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R54-1-20210211","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1111\/j.1600-6143.2006.01493.x","article-title":"Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis.","volume":"6","author":"Cheng","year":"2006","journal-title":"Am J Transplant"},{"key":"R55-1-20210211","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.transproceed.2008.07.100","article-title":"Inhibition of connective tissue growth factor by small interfering RNA prevents renal fibrosis in rats undergoing chronic allograft nephropathy.","volume":"40","author":"Luo","year":"2008","journal-title":"Transplant Proc"},{"key":"R56-1-20210211","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1242\/dev.00505","article-title":"Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development.","volume":"130","author":"Ivkovic","year":"2003","journal-title":"Development"},{"key":"R57-1-20210211","doi-asserted-by":"crossref","first-page":"F1665","DOI":"10.1152\/ajprenal.00495.2006","article-title":"Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: An explanation for the paradoxical effects of VEGF in renal disease.","volume":"292","author":"Nakagawa","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"R58-1-20210211","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1586\/14737159.8.3.301","article-title":"Anti-VEGF therapy: The search for clinical biomarkers.","volume":"8","author":"Longo","year":"2008","journal-title":"Expert Rev Mol Diagn"},{"issue":"4","key":"R59-1-20210211","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1600-6143.2005.00772.x","article-title":"Vascular endothelial growth factor expression and cyclosporine toxicity in renal allograft rejection.","volume":"5","author":"Ozdemir","year":"2005","journal-title":"Am J Transplant"},{"key":"R60-1-20210211","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.2741\/3211","article-title":"HGF as a renotrophic and anti-fibrotic regulator in chronic renal disease.","volume":"13","author":"Mizuno","year":"2008","journal-title":"Front Biosci"},{"key":"R61-1-20210211","doi-asserted-by":"crossref","first-page":"F7","DOI":"10.1152\/ajprenal.00451.2003","article-title":"Hepatocyte growth factor in kidney fibrosis: Therapeutic potential and mechanisms of action.","volume":"287","author":"Liu","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"R62-1-20210211","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1681\/ASN.V1261280","article-title":"Hepatocyte growth factor prevents the development of chronic allograft nephropathy in rats.","volume":"12","author":"Azuma","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R63-1-20210211","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.ki.5001510","article-title":"HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms.","volume":"70","author":"Herrero-Fresneda","year":"2006","journal-title":"Kidney Int"},{"key":"R64-1-20210211","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/CIRCULATIONAHA.107.727347","article-title":"Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.","volume":"118","author":"Powell","year":"2008","journal-title":"Circulation"},{"key":"R65-1-20210211","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/jcp.21183","article-title":"The MET receptor tyrosine kinase in invasion and metastasis.","volume":"213","author":"Benvenuti","year":"2007","journal-title":"J Cell Physiol"},{"key":"R66-1-20210211","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.2741\/3035","article-title":"Bone morphogenetic protein-7 (BMP7) in chronic kidney disease.","volume":"13","author":"Mitu","year":"2008","journal-title":"Front Biosci"},{"key":"R67-1-20210211","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nm888","article-title":"BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.","volume":"9","author":"Zeisberg","year":"2003","journal-title":"Nat Med"},{"key":"R68-1-20210211","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00467-008-0818-x","article-title":"Reversal of experimental renal fibrosis by BMP7 provides insights into novel therapeutic strategies for chronic kidney disease.","volume":"23","author":"Zeisberg","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R69-1-20210211","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.spinee.2008.01.008","article-title":"The use of bone morphogenetic protein in spine fusion.","volume":"8","author":"Hsu","year":"2008","journal-title":"Spine J"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0b013e3181bcccea","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:04:11Z","timestamp":1786039451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200911270-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,27]]},"references-count":68,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181bcccea","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11,27]]}}}